Author:
Guo Jiqiang,Zhang Wen,Zhang Lili,Ding Huaxia,Zhang Jingjing,Song Chen,Zhang Yanfei,Xia Namei,Li Mingfang,Liang Yinming,Hu Xianzhang,Luan Haojiang,Wang Hui
Publisher
Springer Science and Business Media LLC
Reference69 articles.
1. Shimomura, S. et al. Long-term interferon therapy after radiofrequency ablation is effective in treating patients with HCV-associated hepatocellular carcinoma. Hepa. Inter. 5, 559–566, 10.1007/s12072-010-9214-2 (2010).
2. Ma, J. C. et al. Relationship between HBV genotypes and anti-viral therapeutic efficacy of interferon-alpha. Hepatobiliary & pancreatic diseases international : HBPD. INT. 6, 166–171 (2007).
3. Vanaskova, J., Grim, J., Kopecky, J., Kubala, E. & Filip, S. [High-dose interferon alpha in treatment of patients with malignant melanoma, monitoring of predictive and prognostic biomarkers. Klin Onkol. 24, 180–186 (2011).
4. Kovacs, P., Panczel, G., Borbola, K., Juhasz, G. & Liszkay, G. Psychological Changes in Melanoma Patients During Ipilimumab Treatment Compared to Low-Dose Interferon Alpha Therapy-A Follow-Up Study of First Experiences. Pathol. Oncol. Res. 20, 939–944 (2014).
5. Schaefer, M. et al. Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement. J. Hepatol. 57, 1379–1390 (2012).
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献